PlainRecalls

ProRx LLC

Compiled from official public sources by the publisher.

14 recalls on record · Latest: Nov 5, 2025

Subscribe to new ProRx LLC recalls (RSS)

Agency notice ledger

Federal filing book ProRx LLC LIGHT-BOOK · SINGLE-AGENCY

#1,118 of 14,151 · 14 notices · 0.013% archive

  • BOOK 14 notices
  • RANK #1,118 of 14,151
  • SHARE 0.013% archive
  • AGENCY FDA Drug (14)
  • CAT drugs
  • CATS 1 category
  • LATEST Nov 5, 2025
  • PHOTO Actavis Elizabeth LLC

Nearest notice-volume peer: Actavis Elizabeth LLC (0 notice gap)

ProRx LLC accounts for about 0.013% of the 104,423-notice archive on 14 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How ProRx LLC compares to 14,151 recalling firms

ProRx LLC ranks 1,118th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

ProRx LLC vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

14 1118th of 14151 higher than 13,008 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

ProRx LLC in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows ProRx LLC holds about 0.013% of archive notices alongside 14 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Nov 5, 2025

Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-04
FDA Drug Moderate Nov 5, 2025

Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-08
FDA Drug Moderate Nov 5, 2025

Semaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-06
FDA Drug Moderate Nov 5, 2025

Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-09
FDA Drug Moderate Nov 5, 2025

Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-209-03
FDA Drug Moderate Nov 5, 2025

Semaglutide Injection, 12.5/5mL (2.5 mg/mL), 5mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-09
FDA Drug Moderate Nov 5, 2025

Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-02
FDA Drug Moderate Sep 11, 2024

Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01
FDA Drug Moderate Sep 11, 2024

Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-01
FDA Drug Moderate Sep 11, 2024

Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Product, ProRX 267-565-7008, NDC 84139-225-02
FDA Drug Moderate Sep 11, 2024

SEMAGLUTIDE 5mg/2mL (2.5mg/mL), Rx Only 2 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-01
FDA Drug Moderate Sep 11, 2024

TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02
FDA Drug Moderate Sep 11, 2024

TIRZEPATIDE 20 mg/2mL (10/mg/mL), Rx Only, 2mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-01
FDA Drug Moderate Sep 11, 2024

SEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-04

ProRx LLC holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (14 here — thin-book).

Actavis Elizabeth LLC 14 Albertsons Companies, Inc. 14 Allergan Sales, LLC 14 Aurolife Pharma, LLC 14 B&g Foods North America, Inc 14

Similar drugs volume

Nearest multi-notice firms in the same narrow category lane.

Actavis Elizabeth LLC 14 Allergan Sales, LLC 14 Aurolife Pharma, LLC 14 Banner Pharmacy Services, LLC 14

Frequently Asked Questions

How many federal recall notices name ProRx LLC? ▼
PlainRecalls indexes 14 distinct federal recall events naming ProRx LLC, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does ProRx LLC sit among other recalling firms? ▼
ProRx LLC ranks #1,118 of 14,151 by distinct recall-event count among 14,151 firms in this archive (92nd percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of ProRx LLC's notices? ▼
FDA Drug accounts for 14 of this firm's 14 indexed notices.
What product category dominates ProRx LLC's filing book? ▼
Filings for ProRx LLC span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
ProRx LLC: 14 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming ProRx LLC; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026